e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Asthma: basic science and clinical studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The interplay of LXA4 and glucocorticoid receptor-based mechanisms in airway inflammation of childhood asthma
R. Gagliardo, S. La Grutta, P. Chanez, A. Sala, L. Siena, C. Di Sano, L. Riccobono, G. Viegi, M. Gjomarkaj, M. Profita (Palermo, Milano, Italy; Marseille, France)
Source:
Annual Congress 2011 - Asthma: basic science and clinical studies
Session:
Asthma: basic science and clinical studies
Session type:
Poster Discussion
Number:
3267
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Gagliardo, S. La Grutta, P. Chanez, A. Sala, L. Siena, C. Di Sano, L. Riccobono, G. Viegi, M. Gjomarkaj, M. Profita (Palermo, Milano, Italy; Marseille, France). The interplay of LXA4 and glucocorticoid receptor-based mechanisms in airway inflammation of childhood asthma. Eur Respir J 2011; 38: Suppl. 55, 3267
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Molecular-cellular mechanisms of combined airway hyperresponsiveness in asthma
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
The association between obesity and asthma: interactions between systemic and airway inflammation
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Novel concepts in airway inflammation and remodelling in asthma
Source: Eur Respir J 2015; 46: 1796-1804
Year: 2015
The potential mechanism of Th17/Treg imbalance in the microenvironments of chronic inflammation and allergic asthma
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 433s
Year: 2006
Understanding the mechanisms of LASSBio596 on airway remodeling in asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Year: 2007
Corticosteroid effects on airway neuroplasticity in experimental models of asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
The effects of capsaicin on airway inflammation in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 586s
Year: 2004
The mechanisms of glucocorticoid (GC)-induced lymphocyte apoptosis in atopic bronchial asthma (ABA)
Source: Eur Respir J 2002; 20: Suppl. 38, 29s
Year: 2002
A potential role of P2X
7
R in allergic airway inflammation
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept